Corpay Inc <CPAY.N>: Morgan Stanley Raises Target Price to $415.00 From $400.00
CPAY•Related News
Vistra Corp <VST.N>: Raymond James cuts target price to $186 from $202
VST•
First Tracks Biotherapeutics Inc <TRAX.O>: Wedbush Raises Target Price to $60 From $30
TRAX•
GSK H1 FY26 profit attributable to shareholders rises to $2.91 billion; turnover increases to $21.49 billion
GSK•
Boeing Q2 Adjusted EPS USD -0.76 Vs. IBES Estimate USD -0.3
BA•
Hubbell Q2 results beat estimates; raises annual profit forecast
HUBB•